Eosinophilic airway inflammation induced by expressing-IL13 gene was not improved by treating with an EGFR inhibitor alone, but the combination therapy of EGFR inhibitor and dexamethasone suppressed airway eosinophilia and neutrophilic inflammation. The gene discussed is IL13; the disease is Increased total eosinophil count.